Spectrum Wealth Counsel LLC Invests $8.47 Million in Aflac Incorporated (NYSE:AFL)

Key Points

• Spectrum Wealth Counsel LLC has invested approximately $8.47 million in Aflac Incorporated, acquiring 76,171 shares of its stock during the first quarter.
• Aflac's recent financial performance saw it report $1.66 EPS for the last quarter, missing analysts' expectations and experiencing a 37.5% year-over-year decline in revenue.
• The company's dividend was recently set at $0.58 per share, providing an annual yield of 2.24% with a payout ratio of 36.25%.

Spectrum Wealth Counsel LLC acquired a new position in Aflac Incorporated (NYSE:AFL - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 76,171 shares of the financial services provider's stock, valued at approximately $8,469,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AFL. Norges Bank bought a new position in Aflac during the fourth quarter valued at about $349,699,000. GAMMA Investing LLC increased its stake in Aflac by 12,313.9% during the first quarter. GAMMA Investing LLC now owns 1,504,067 shares of the financial services provider's stock valued at $167,237,000 after acquiring an additional 1,491,951 shares during the period. Northern Trust Corp increased its stake in Aflac by 22.9% during the fourth quarter. Northern Trust Corp now owns 7,296,014 shares of the financial services provider's stock valued at $754,700,000 after acquiring an additional 1,357,753 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Aflac by 11.9% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,250,905 shares of the financial services provider's stock valued at $543,154,000 after acquiring an additional 556,394 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Aflac during the fourth quarter valued at about $48,081,000. 67.44% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently issued reports on AFL. Wall Street Zen lowered Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Morgan Stanley upped their price objective on Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. JPMorgan Chase & Co. upped their price objective on Aflac from $96.00 to $100.00 and gave the company a "neutral" rating in a research note on Tuesday, July 8th. Piper Sandler upped their price objective on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Finally, Raymond James Financial lowered their price objective on Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a research note on Thursday, May 29th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $108.15.

Aflac Stock Up 0.9%

Shares of AFL opened at $103.40 on Friday. The firm has a market capitalization of $55.90 billion, a price-to-earnings ratio of 16.16, a PEG ratio of 3.19 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.09 and a current ratio of 0.09. The business's fifty day moving average price is $103.04 and its two-hundred day moving average price is $105.18. Aflac Incorporated has a 52 week low of $94.03 and a 52 week high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The firm had revenue of $3.40 billion during the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. The firm's quarterly revenue was down 37.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.66 earnings per share. On average, analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were paid a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a yield of 2.24%. The ex-dividend date was Wednesday, May 21st. Aflac's payout ratio is presently 36.25%.

Insider Buying and Selling

In other Aflac news, Director Arthur Reginald Collins sold 2,750 shares of Aflac stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $105.70, for a total value of $290,675.00. Following the sale, the director owned 6,728 shares of the company's stock, valued at $711,149.60. This trade represents a 29.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the firm's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the transaction, the director owned 70,992 shares of the company's stock, valued at $7,496,045.28. The trade was a 34.26% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 40,750 shares of company stock valued at $4,304,295. 0.90% of the stock is owned by company insiders.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.